Discover a study comparing two types of treatment for bladder cancer, robot-assisted radical cystectomy and intracorporeal ...

The people you spend the most time with outside your home might be playing a role in the composition of the microbes residing ...

Shares of Mirum Pharmaceuticals, Inc. MIRM have rallied 90.9% in the past six months compared with the industry’s increase of ...

GSK plc GSK announced positive headline data from the phase III GLISTEN study, which is evaluating its investigational ...

UK pharma major GSK today announced positive headline results of GLISTEN, the ongoing global Phase III clinical trial ...

Interim results from the ongoing GLISTEN trial of linerixibat, GSK's targeted inhibitor of the ileal bile acid transporter ...

PBC patients receiving linerixibat saw statistically significant improvement in cholestatic pruritus - or relentless itch.

Drugmaker GSK said on Tuesday that its linerixibat candidate had shown "positive" Phase III results in cholestatic pruritus ...

PBC treatments are available, even after the setback to Intercept Pharmaceuticals’ Ocaliva, but they are unable to reduce ...

GSK announces positive results from GLISTEN phase III trial of linerixibat in adults with cholestatic pruritus (relentless itch) associated with PBC: London, UK Wednesday, Novembe ...